Kalina Ganeva

Kalina Ganeva

Auto-generated profile, based on publicly available information

Kalina Ganeva

Medical University of Varna

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2021 in Folia Medica
Verified
Journal Article
Open access
PDF file
KGKalina Ganeva
Kalina Ganeva
PSPetar Shivachev
Petar Shivachev
NSNikolay Sapundzhiev
Nikolay Sapundzhiev
LNLora Nikiforova
Lora Nikiforova
Infantile hemangioma is one of the most common benign tumors of infancy. The natural evolution includes rapid growth followed by gradual involution. Airway hemangiomas are not that common, but they can lead to dyspnoea, as well as to life-threatening complications. Two children aged 3 months were admitted to the Pediatric Department with difficulties in breathing and with biphasic stridor. They had previously been hospitalized because of the same symptoms and misdiagnosed as having an upper respiratory tract infection. The previous treatment included intravenous or inhaled corticosteroids, without any significant improvement. Laryngoscopy was performed for both of the children. There was a mass in the subglottic area with the appearance of a hemangioma causing significant airway stenosis. We started treatment with propranolol at a dose of 1 mg/kg/day twice daily. The dose was gradually increased up to 3 mg/kg/day, under close monitoring. In the first 7 to 10 days after initiation of treatment, we observed a significant improvement of the respiratory distress. The second laryngoscopy showed an almost complete involution of the mass in the subglottis.  The focus of this article will be primarily on the clinical presentation and the therapeutic response of subglottic hemangioma, along with a literature review on the subject.

25 August 2022 in The Turkish Journal of Pediatrics
Verified
Journal Article
Closed access
KGKalina Ganeva
Kalina Ganeva
PSPetar Shivachev
Petar Shivachev
DADeyan Anakievski
Deyan Anakievski
KKKalin Kalchev
Kalin Kalchev
BBBoyan Balev
Boyan Balev
VIVioleta Iotova
Violeta Iotova
Background. Childhood hypertension is getting more attention in recent years. We present a case report of a rare cause of secondary arterial hypertension in a teenage girl -a solitary fibrous tumor of the kidney. The case demonstrates that standard imaging techniques, computed tomography and magnetic resonance imaging, are not fully reliable in the diagnosis of renovascular hypertension.Case. A 15-year old girl was admitted to the Pediatric Department because of episodes of stiffness in the limbs, accompanied by pale skin and lips, dated 4 months back. During these episodes, high blood pressure up to 160/100 mmHg was measured. A 24-hour blood pressure monitoring demonstrated arterial hypertension stage II. Renovascular hypertension was suspected, but the computed tomography examination of the abdomen showed normal-sized renal arteries. In the left kidney hilum, an intraparenchymal formation was discovered. The data presented a non-specific lesion with a wide differential diagnosis. Given the fact that the patient had been treated with an ACE-inhibitor, serum renin level could not be correctly interpreted. The lesion was removed through a laparoscopic intervention. Intraoperatively, the tumor was compressing a small intra-renal vessel -a finding that hadn't been discovered by the previous imaging studies. The final pathologist diagnosis was: solitary fibrous tumor. During the next six months of follow-up, the maximal blood pressure values of the patient were up to 120/80 mmHg.Conclusions. Solitary fibrous tumors of the kidneys are infrequent in children. The presented case displays a rare form of initial clinical manifestation of this tumor. It is also a demonstration that standard imaging techniques are not able to get a precise visualization of the small intra-renal vessels. At the same time, the decision of whether or not to perform a more invasive procedure should be based on the clinical conditions and risks of the individual patient.

6 April 2022 in Bulgarian Cardiology
Verified
Journal Article
Open access
PDF file
PSPetar Shivachev
Petar Shivachev
KGKalina Ganeva
Kalina Ganeva
DKDarina Krumova
Darina Krumova
MGMiglena Georgieva
Miglena Georgieva
PPPetar Petrov
Petar Petrov
ПSПетър Петров Petar Shivachev
Петър Петров Petar Shivachev
Anorexia nervosa is an eating disorder with a multisystemic nature, affecting female adolescents predominantly. The disease is potentially fatal with cardiac complications being the leading cause. We present a clinical case of a 16-year-old girl with anorexia nervosa after a mental trauma, hospitalized in our Clinic in an extremely severe, pre comatose state with weight 26 kg, BSA – 1.12 m2 and BMI – 10.4. On the background of severe abnormalities in homeostasis, bradycardia with left ventricular extrasystoles in bigeminy and episodes of tachycardia with a frequency of 238/min. Echocardiography revealed reduce in the heart size and the left ventricular muscle mass, MI – I + degree and a small, apical pericardial effusion. During the echocardiographic follow-up, there was signifi cant hypertrophy of the left ventricle with obstruction in the outfl ow tract, with a reduction in ventricular size, without signifi cant change in left ventricular muscle mass. As a result of long-term, comprehensive treatment, with the participation of a team of specialists, the patient achieved true behavioural criticality, improved food tolerance, weight gain up to 46 kg with BMI - 18.4 and normalization of cardiac anatomy. Cardiac complications of anorexia nervosa are common, varied, and potentially lethal and require targeted cardiac monitoring and treatment. Left ventricular hypertrophy with obstruction in the ventricular outfl ow tract, fi rst described in 2006, is a rare but potentially fatal cardiac complication in patients with the disease.

27 April 2021 in ScienceOpen Preprints
Verified
Preprint
Open access
PDF file
AHAdriana Hadzhieva-Hristova
Adriana Hadzhieva-Hristova
MBMartin Boyadzhiev
Martin Boyadzhiev
KGKalina Ganeva
Kalina Ganeva
YDYoana Dyankova
Yoana Dyankova
TKTeodora Karamfilova
Teodora Karamfilova
VIVioleta Iotova
Violeta Iotova
Background Multisystem Inflammatory Syndrome in children related to COVID-19 (MIS-C) is a new condition the aftermath of which is yet to be studied both in Bulgaria and globally. Up to mid December 2020, world COVID-19 fatalities are put at 1 582 674, according WHO statistics. Case Presentation Summary We present a 15 years old patient with MIS-C, diagnosed with acute abdomen, operated andtreated for septic shock syndrome. The current situation represents a major clinical challenge in part due to the complex differential diagnosis involved: acute abdomen, septic shock, autoimmune diseases (Lupus erythematosus, Juvenile idiopathic arthritis, Kawasaki disease, Acquired immune deficiency, Crohn`s disease, Ulcer colitis), acute myocarditis. At the same time, other symptoms observed in children with COVID-19 such as skin rashes, lymphadenopathy, conjunctivitis are not presented inour patient. We did not observe any myocardial injury, however she went into an acute vasodilatory shock with tachycardia, reduced kidney perfusion pressure and oliguria. Learning Points/Discussion Effects of SARS-CoV-2 infection on patients will be a subject of analysis and clinical research. Differential diagnosis of the multisystem inflammation syndrome in children, clinical experience and new therapeutic strategies are the key to reducing mortality and long-term complications in the affected patients.

6 April 2022 in Bulgarian Cardiology
Verified
Journal Article
Open access
PDF file
КГКалина Ганева
Калина Ганева
ПGПетър Шивачев Kalina Ganeva
Петър Шивачев Kalina Ganeva
PSPetar Shivachev
Petar Shivachev
Thalassemias are a group of inherited disorders, that require regular lifelong blood transfusions, which are vital for the normal development and life of the patients. With time, complications occur due to iron deposition in internal organs with subsequent chronic hemochromatosis development and predominantly affecting the heart, the liver and the endocrine glands. Despite the absence of clinical symptoms in young patients, enough data are supporting the fact that early myocardial iron deposition occurs. This necessitates the introduction of suffi ciently reliable methods and techniques for the detection and follow-up of early heart disorders before the onset of symptoms. Evaluation of myocardial iron deposition by the T2* MRI technique is established as a reliable, non-invasive method with good reproducibility and a low percentage of variability. Echocardiography as a method does not give information concerning the iron deposition in the heart but is easily applicable, safe and widespread for screening and follow up of patients. The use of new technique such as longitudinal strain makes the method almost comparable for the assessment of early subclinical myocardial damage. Although still in the fi eld of research, the identifi cation of specifi c miRNAs associated with cardiac stroke, fi brosis and remodeling is emerging as a new, potential biomarker for myocardial damage that could support the overall cardiovascular assessment of patients. This review will focus on current manifestations of cardiac complications in young patients with beta-thalassemia major, as well as the noninvasive methods for assessing cardiac function described above.

12 December 2022 in Scripta Scientifica Medica
Verified
Journal Article
Open access
PDF file
KGKalina Ganeva
Kalina Ganeva
PSPetar Shivachev
Petar Shivachev
TCTrifon Chervenkov
Trifon Chervenkov
VKValeria Kaleva
Valeria Kaleva
Introduction: MicroRNAs are small non-coding RNA molecules, which possess the potential to become biomarkers for several cardiac diseases. Investigations of microRNAs, associated with cardiac damage in children and young patients with beta-thalassemia major, would contribute to a better understanding of their role in commonly occurring cardiac complications, as well as examine the possibility of being used as diagnostic markers. Aim: The present study is aimed at investigating the expression of specific microRNAs associated with cardiac damage in children and young adults with beta-thalassemia major, as well as at comparing the results with the cardiac function in the examined subjects. Patients and Methods: The design of the study was prospective and included 50 subjects of whom 27 patients were with beta-thalassemia major (13 girls and 14 boys) at an average age of 15.14 years, and 23 healthy controls matched for sex and age. The average patient age was 15.14 years (between 5 and 24 years), and the average healthy control’s age was 16.1 years (between 6 and 23 years). From all of the subjects, the relative quantity of 5 microRNAs in blood serum was determined via RT-qPCR. A thorough echocardiographic examination was performed to evaluate cardiac function. Results: Five specific types of microRNAs, associated with acute cardiac damage, cardiac fibrosis, and remodeling, were studied. The results showed that hsa-miR-30a-5p is significantly downregulated, and hsa-miR-150-5p is upregulated in patients with beta-thalassemia major, in comparison to healthy controls. Conclusion: The upregulation of hsa-miR-30a-5p in patients with beta-thalassemia major could be a prognostic marker for a future cardiac injury that is not yet clinically manifested. The different expression pattern of hsa-miR-150-5p is more likely to be associated with the disease itself.